ABCC1 and cancer: Many drugs, including daunorubicin (DRN), imatinib, nilotinib, taxol, and doxorubicin, among others, can be expelled from cancer cells that overexpress P-gp and multidrug resistance-associated protein 1 (MRP1) transporter (Gottesman et al., 2002; Kosztyu et al., 2014).